Browse drugs

…(c) Long-term tumor rechallenge assay without or with secretory IL-15 armoring, over 96 days, with 27 semiweekly challenges with Raji…

…ted with defined cytokine combinations (IL-2, IL-15, IL-18, and IL-21). Cultures were maintained for 10–14 days without media exchang…

…d.aaf2341Leong JW, Chase JM, Romee R, et al. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity I…

…bank of healthy donor NKTs that co-express a CD19-specific CAR, IL-15, and shRNA targeting beta-2-microglobulin and CD74 to downregul…

…nuclear cells (PBMCs) were collected from NHL patients prior to NKX019 infusion. Single cell transcriptome and paired TCR sequencing w…

…nt on the same cell.Conclusions Together, our data suggest that Daiad-2/15 could potentiate the systemic delivery of a highly potent immun…

…e of therapeutics entering clinical development. In particular, cytokines have received significant attention due to their potential to c…

… Furthermore, the combination of HEK293-derived IL-2, IL-7, and IL-15 resulted in robust expansion of T cells with a favorable phenot…

…term tumor control compared with CAR-NK cells supplemented with IL-15. Similar results were seen using C7R-expressing CD19.CAR-NK cel…